# 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Study · id `cardio:ct-nct01906489` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01906489](<https://clinicaltrials.gov/study/NCT01906489>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01906489

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.

## Technical summary

Registry record NCT01906489. Randomized; quadruple masking; primary purpose treatment. Start 2013-07-23 (actual); primary completion 2014-09-03 (actual). Results posted on 2022-07-01.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 210 participants (enrolled count; ClinicalTrials.gov record NCT01906489, source copy `cardio:ctgov-nct01906489-2022-07-21`, retrieved 2026-10-26)
- Started: 2013-07-23 (actual) (ClinicalTrials.gov record NCT01906489, source copy `cardio:ctgov-nct01906489-2022-07-21`, retrieved 2026-10-26)
- Primary completion: 2014-09-03 (actual) (ClinicalTrials.gov record NCT01906489, source copy `cardio:ctgov-nct01906489-2022-07-21`, retrieved 2026-10-26)
- Completion: 2014-09-03 (actual) (ClinicalTrials.gov record NCT01906489, source copy `cardio:ctgov-nct01906489-2022-07-21`, retrieved 2026-10-26)
- Results first posted: 2022-07-01 (ClinicalTrials.gov record NCT01906489, source copy `cardio:ctgov-nct01906489-2022-07-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01906489, source copy `cardio:ctgov-nct01906489-2022-07-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01906489-2022-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
- Condition: Anemia
- Condition: Chronic Kidney Disease
- Intervention (Drug): AKB-6548
- Intervention (Drug): Placebo
- Lead sponsor: Akebia Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Akebia Therapeutics (`cardio:org-akebia-therapeutics`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease (`cardio:pubmed-27650732`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8002802e14a14eab3f705b33944f681ba820d520302ebc35c1a5b13d5e7abca8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
